Company profile for Phytanix Bio

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Phytanix Bio is an innovative pharmaceutical company focused on developing cannabinoid and cannabinoid-like drug candidates to address unmet medical needs. Leveraging our expertise in botanically-derived and chemically synthesized "hybrid" molecules, we prioritize safety and tolerability to minimize development risks. Our capital-efficient approach targets rapid, cost-effective advancement through preclinical and clinical stag...
Phytanix Bio is an innovative pharmaceutical company focused on developing cannabinoid and cannabinoid-like drug candidates to address unmet medical needs. Leveraging our expertise in botanically-derived and chemically synthesized "hybrid" molecules, we prioritize safety and tolerability to minimize development risks. Our capital-efficient approach targets rapid, cost-effective advancement through preclinical and clinical stages, ensuring strong intellectual property protection and shareholder value.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
701 Anacapa Street Suite C Santa Barbara CA 93101
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

euroPLX 90 Lisbon

Not Confirmed

envelop Contact Supplier

euroPLX 90 Lisbon

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/protagenic-therapeutics-receives-3.1-million-from-recent-warrant-acti-1030285

ACCESSWIRE
21 May 2025

https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/protagenic-therapeutics-and-phytanix-announce-business-combination-to-1029131

ACCESSWIRE
19 May 2025
Phytanix Bio Publishes New Investor Deck
Phytanix Bio Publishes New Investor Deck

30 Jul 2024

// GLOBENEWSWIRE

https://www.globenewswire.com/news-release/2024/07/30/2921041/0/en/Phytanix-Bio-Publishes-New-Investor-Deck-Highlighting-Strategic-Vision-and-Growth-Potential.html

GLOBENEWSWIRE
30 Jul 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty